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ABSTRACT 
Occurrence of pharmaceutical residues in drinking water has been widely reported in countries 
that have registered steady economic growth. This can exert concerns among the general 
consumers, prompting them to explore the potential human health risks associated with 
continuous exposure to pharmaceuticals. However, such an occurrence is rarely reported in 
developing or under-developed countries. To give more contexts, this study looked at the 
presence of nine pharmaceutical residues in drinking water (amoxicillin, caffeine, 
chloramphenicol, ciprofloxacin, dexamethasone, diclofenac, nitrofurazone, sulfamethoxazole, 
and triclosan) at Putrajaya residential area in Malaysia. Additionally, the potential health risks 
associated with contaminated drinking water were investigated. This study has found the 
presence of pharmaceutical residue concentrations up to 0.38 ng/L, with the highest 
concentration of caffeine (0.38 ng/L) and the lowest concentration of diclofenac (0.14 ng/L). 
In comparison, all the nine pharmaceutical residues were substantially lower than previously 
reported studies. In general, Hazard Quotient (HQ) values indicated that low potential health 
hazards were present for all age groups. Nevertheless, quantitative occurrences of 
pharmaceutical residues in drinking water will help guide future toxicological studies to 
examine other chronic effects, while canvassing for proper framework to look into the water 
risk management and regulation in Malaysia.  
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